Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P14
Within normal range
vs 3Y Ago
-2.9x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-116.64%
2024-704.38%
2023-77.00%
202240.34%
2021109.23%
2020-182.70%
201957.47%
2018-52.44%
2017-9.64%
20165.14%